Skip to main content


Fig. 2 | Cancer Communications

Fig. 2

From: The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study

Fig. 2

The association between heart rate changes in TNBC patients and chemotherapy drugs. No matter what the chemotherapy drugs are, the heart rate of the patients is increased with nearly every chemotherapy cycle compared with baseline. TNBC triple-negative breast cancer

Back to article page